α2,6-hyposialylation of c-Met abolishes cell motility of ST6Gal-I-knockdown HCT116 cells
Cited by 29
Related Papers
Targeting Epigenetic Crosstalk as a Therapeutic Strategy for EZH2-Aberrant Solid Tumors
|Cell|2018|271
S9, a Novel Anticancer Agent, Exerts Its Anti-Proliferative Activity by Interfering with Both PI3K-Akt-mTOR Signaling and Microtubule Cytoskeleton
|PLoS ONE|2009|55
<i>Grateloupia longifolia</i> polysaccharide inhibits angiogenesis by downregulating tissue factor expression in HMEC‐1 endothelial cells
|British Journal of Pharmacology|2006|50
c-Jun Protects Hypoxia-Inducible Factor-1α from Degradation via Its Oxygen-Dependent Degradation Domain in a Nontranscriptional Manner
|Cancer Research|2009|49
Discovering novel quercetin-3-O-amino acid-esters as a new class of Src tyrosine kinase inhibitors
|European Journal of Medicinal Chemistry|2008|38